Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 11 articles:
HTML format

Single Articles

    March 2021
  1. ASHINA M, Katsarava Z, Do TP, Buse DC, et al
    Migraine: epidemiology and systems of care.
    Lancet. 2021 Mar 25. pii: S0140-6736(20)32160.
    PubMed     Abstract available

  2. ASHINA M, Buse DC, Ashina H, Pozo-Rosich P, et al
    Migraine: integrated approaches to clinical management and emerging treatments.
    Lancet. 2021 Mar 25. pii: S0140-6736(20)32342.
    PubMed     Abstract available

  3. ASHINA M, Terwindt GM, Al-Karagholi MA, de Boer I, et al
    Migraine: disease characterisation, biomarkers, and precision medicine.
    Lancet. 2021 Mar 25. pii: S0140-6736(20)32162.
    PubMed     Abstract available

    December 2020
  4. CROOP R, Lipton RB, Kudrow D, Stock DA, et al
    Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32544.
    PubMed     Abstract available

    Oral rimegepant for migraine prevention.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32624.

    July 2020
  6. FANDLER-HOFLER S, Enzinger C, Gattringer T
    Speechless from pain: migraine with prolonged aura.
    Lancet. 2020;396:e11.

  7. VGONTZAS A, Renthal W
    Predicting erenumab adverse events with single-cell genomics.
    Lancet. 2020;396:95-96.

    June 2020
  8. GASPARINI S, Torino C, Branca D, Ferlazzo E, et al
    Testing rimegepant for migraine-time to revise the trial design?
    Lancet. 2020;395:1901.

  9. CROOP R, Goadsby PJ, Stock DA, Lipton RB, et al
    Testing rimegepant for migraine-time to revise the trial design? - Authors' reply.
    Lancet. 2020;395:1901-1902.

    November 2019
    Lancet. 2019;394:1897.

    October 2019
  11. CHARLES A, Pozo-Rosich P
    Targeting calcitonin gene-related peptide: a new era in migraine therapy.
    Lancet. 2019 Oct 23. pii: S0140-6736(19)32504.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.